Changes for page Customer segments in Health and Wellbeing Living Labs
Last modified by Sarantis Dimitriadis on 2023/12/08 13:20
From version 5.4
edited by Sarantis Dimitriadis
on 2022/06/02 10:00
on 2022/06/02 10:00
Change comment:
There is no comment for this version
To version 5.1
edited by XWikiGuest
on 2022/01/10 15:43
on 2022/01/10 15:43
Change comment:
Added annotation on "Researcher expertise"
Summary
-
Page properties (2 modified, 0 added, 0 removed)
Details
- Page properties
-
- Author
-
... ... @@ -1,1 +1,1 @@ 1 -XWiki. Sarantis1 +XWiki.XWikiGuest - Content
-
... ... @@ -1,360 +358,3 @@ 1 -(% class="western" lang="en-GB" style="text-align:justify" %) 2 -(% lang="en-US" %)**End user:** A person who ultimately uses or is intended to ultimately use the product, service or process. In living lab project, end user is defined as a primary study participant who voluntarily participates research after giving informed consent to be the subject of the research. 3 - 4 -(% class="western" lang="en-GB" style="text-align:justify" %) 5 -(% lang="en-US" %)**Living lab research infrastructure end user:** A person or organization who(%%) (% lang="en-US" %)purchases or uses living lab research infrastructure services to conduct a specific contract based research and development activity (often focusing on specifically defined end user group). Living lab research infrastructure end user can also be study participant (a.k.a. end user), if living project is focusing on developing living lab services and infrastructure. 6 - 7 -(% class="western" lang="en-GB" style="text-align:justify" %) 8 -(% lang="en-US" %)End users can be classified to non-professional and professional groups. Typical non-professional and professional end-user groups in health and wellbeing includes the following: 9 - 10 -* ((( 11 -(% lang="en-US" %)**Non-professional end users:** 12 - 13 -* (% lang="en-US" %)**Consumers: **Those who buy goods or services for their own use. 14 - 15 -* (% lang="en-US" %)**Public health and social service clients: **Those who use public services. 16 -))) 17 - 18 -* ((( 19 -(% lang="en-US" %)**Professional end users** 20 - 21 -* (% lang="en-US" %)**Health professionals and managers:** A person providing health care treatment and advice based on formal training and experience. Also known as healthcare professional or healthcare worker. 22 - 23 -* (% lang="en-US" %)**Social care workers and managers:** Those providing the practical support to help people cope with the day-to-day business of living based on formal training and experience. 24 - 25 -* (% lang="en-US" %)**Policy and decisions makers:** Those responsible for making policies and decisions at local, regional, national or international level. 26 -))) 27 - 28 -(% class="western" lang="en-GB" %) 29 -(% lang="en-US" %)**Business-to-Business Customer (B2B):** B2B-customer is an organization that purchases living lab services from a living lab. B2B-customers can be classified to private, public, education/ research, civil society organizations and networks/cluster groups as follows: 30 - 31 -* ((( 32 -(% lang="en-US" %)**Private sector organizations: **(business developers and researchers) 33 - 34 -* (% lang="en-US" %)Tangible equipment and device manufactures 35 - 36 -* (% lang="en-US" %)Health and social service providers 37 - 38 -* (% lang="en-US" %)e-health, IT system and digital technology providers 39 - 40 -* (% lang="en-US" %)Wellbeing and wellness service providers 41 - 42 -* (% lang="en-US" %)Pharmaceutical companies 43 -))) 44 - 45 -* ((( 46 -(% lang="en-GB" %) 47 -(% lang="en-US" %)**Public sector organizations:** 48 - 49 -* (% lang="en-US" %)**Local level: **Municipals, cities and other local level public organizations providing e.g. health and social services such as primary health care. 50 - 51 -* (% lang="en-US" %)**Regional level: **e.g.** **Regional** **hospitals providing secondary and tertiary care,** **councils, parliaments, and governments as well as other administrative organizations operating at regional level. 52 - 53 -* (% lang="en-US" %)**National level: **Government agencies, departments or temporary pointed working groups responsible for the specific functions such as health and social services. 54 - 55 -* (% lang="en-US" %)**International level: **European commission departments and agencies as well as other organizations operating at international and transnational level. 56 - 57 -* (% lang="en-US" %)**Public funder:** Government or other European, national, regional or local public institutions who is providing public funding for a specific living lab living lab research project via call for application process. 58 -))) 59 - 60 -* ((( 61 -(% lang="en-GB" %) 62 -(% lang="en-US" %)**Education and research organizations:** 63 - 64 -* (% lang="en-US" %)**Higher education institutes:** Universities and Universities of Applied Sciences 65 - 66 -* (% lang="en-US" %)**Other educational institutes** covering early childhood, primary, secondary and tertiary education 67 - 68 -* (% lang="en-US" %)**Public research institutions/organizations** such as technical research centers and government laboratories. 69 - 70 -* (% lang="en-US" %)**Private research organizations** such as technology and innovation centers 71 -))) 72 - 73 -* ((( 74 -(% lang="en-GB" %) 75 -(% lang="en-US" %)**Civil society organizations:** 76 - 77 -* (% lang="en-US" %)Non-governmental organizations (NGO) and nonprofit entities operating at international, national, regional or local level. 78 -))) 79 - 80 -* ((( 81 -(% lang="en-GB" %) 82 -(% lang="en-US" %)**Networks and clusters:** 83 - 84 -* (% lang="en-US" %)Company cluster organizations and company networks 85 -* (% lang="en-US" %)International, national, regional and local networks 86 -))) 87 - 88 -(% class="western" lang="en-GB" %) 89 -(% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in Table . 90 - 91 - 92 -(% cellspacing="0" class="table-striped" dir="ltr" style="margin-left:auto; margin-right:auto" %) 93 -|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:5px; padding:0in 0.08in; width:628px" %)((( 94 -(% class="western" lang="en-GB" style="text-align:center" %) 95 -(% lang="en-US" style="font-family:Calibri,serif" %)**Age or age group** 96 -))) 97 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)((( 98 -(% class="western" lang="en-GB" %) 99 -(% lang="en-US" style="font-family:Calibri,serif" %)Specific age range 100 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 101 -(% class="western" %) 102 - 103 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 104 -(% class="western" %) 105 - 106 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)((( 107 -(% class="western" %) 108 - 109 -))) 110 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:6px; padding:0in 0.08in; width:146px" %)((( 111 -(% class="western" lang="en-GB" %) 112 -(% lang="en-US" style="font-family:Calibri,serif" %)Elderly 113 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 114 -(% class="western" lang="en-GB" %) 115 -(% lang="en-US" style="font-family:Calibri,serif" %)Adults 116 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 117 -(% class="western" lang="en-GB" %) 118 -(% lang="en-US" style="font-family:Calibri,serif" %)Youth 119 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)((( 120 -(% class="western" lang="en-GB" %) 121 -(% lang="en-US" style="font-family:Calibri,serif" %)Children 122 -))) 123 -|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)((( 124 -(% class="western" %) 125 - 126 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)((( 127 -(% class="western" %) 128 - 129 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)((( 130 -(% class="western" %) 131 - 132 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:147px" %)((( 133 -(% class="western" %) 134 - 135 -))) 136 -|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)((( 137 -(% class="western" lang="en-GB" style="text-align:center" %) 138 -(% lang="en-US" style="font-family:Calibri,serif" %)**Health status** 139 -))) 140 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:6px; padding:0in 0.08in; width:146px" %)((( 141 -(% class="western" lang="en-GB" %) 142 -(% lang="en-US" style="font-family:Calibri,serif" %)Healthy 143 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 144 -(% class="western" lang="en-GB" %) 145 -(% lang="en-US" style="font-family:Calibri,serif" %)Patient 146 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 147 -(% class="western" lang="en-GB" %) 148 -(% lang="en-US" style="font-family:Calibri,serif" %)Rehabilitant 149 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)((( 150 -(% class="western" lang="en-GB" %) 151 -(% lang="en-US" style="font-family:Calibri,serif" %)Recovered/Survivor 152 -))) 153 -|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)((( 154 -(% class="western" %) 155 - 156 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)((( 157 -(% class="western" %) 158 - 159 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)((( 160 -(% class="western" %) 161 - 162 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:147px" %)((( 163 -(% class="western" %) 164 - 165 -))) 166 -|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)((( 167 -(% class="western" lang="en-GB" style="text-align:center" %) 168 -(% lang="en-US" style="font-family:Calibri,serif" %)**A specific disease, disorder or disability** 169 -))) 170 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)((( 171 -(% class="western" lang="en-GB" %) 172 -(% lang="en-US" style="font-family:Calibri,serif" %)ADHD 173 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 174 -(% class="western" lang="en-GB" %) 175 -(% lang="en-US" style="font-family:Calibri,serif" %)Dementia 176 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 177 -(% class="western" lang="en-GB" %) 178 -(% lang="en-US" style="font-family:Calibri,serif" %)Parkinsons’ disease 179 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)((( 180 -(% class="western" lang="en-GB" %) 181 -(% lang="en-US" style="font-family:Calibri,serif" %)Loneliness and Social Isolation 182 -))) 183 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)((( 184 -(% class="western" lang="en-GB" %) 185 -(% lang="en-US" style="font-family:Calibri,serif" %)Autism 186 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 187 -(% class="western" lang="en-GB" %) 188 -(% lang="en-US" style="font-family:Calibri,serif" %)Down syndrome 189 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 190 -(% class="western" lang="en-GB" %) 191 -(% lang="en-US" style="font-family:Calibri,serif" %)Physical disability 192 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)((( 193 -(% class="western" lang="en-GB" %) 194 -(% lang="en-US" style="font-family:Calibri,serif" %)Mental health 195 -))) 196 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)((( 197 -(% class="western" lang="en-GB" %) 198 -(% lang="en-US" style="font-family:Calibri,serif" %)Cardiovascular disease 199 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 200 -(% class="western" lang="en-GB" %) 201 -(% lang="en-US" style="font-family:Calibri,serif" %)Idiopathic pulmonary fibrosis (IPF) 202 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 203 -(% class="western" lang="en-GB" %) 204 -(% lang="en-US" style="font-family:Calibri,serif" %)Sleep apnea/apnea 205 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)((( 206 -(% class="western" lang="en-GB" %) 207 -(% lang="en-US" style="font-family:Calibri,serif" %)Mild cognitive impairment 208 -))) 209 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)((( 210 -(% class="western" lang="en-GB" %) 211 -(% lang="en-US" style="font-family:Calibri,serif" %)Chronic Obstructive Pulmonary Disease (COPD) 212 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 213 -(% class="western" lang="en-GB" %) 214 -(% lang="en-US" style="font-family:Calibri,serif" %)Language disability 215 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 216 -(% class="western" lang="en-GB" %) 217 -(% lang="en-US" style="font-family:Calibri,serif" %)Substance abuse (drugs, alcohol) 218 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)((( 219 -(% class="western" lang="en-GB" %) 220 -(% lang="en-US" style="font-family:Calibri,serif" %)Multiple sclerosis 221 -))) 222 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:44px; padding:0in 0.08in; width:146px" %)((( 223 -(% class="western" lang="en-GB" %) 224 -(% lang="en-US" style="font-family:Calibri,serif" %)Cognitive disorder (mild, major) 225 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 226 -(% class="western" lang="en-GB" %) 227 -(% lang="en-US" style="font-family:Calibri,serif" %)Intellectual disability/ Learning difficulty/ Mental retardation 228 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 229 -(% class="western" lang="en-GB" %) 230 -(% lang="en-US" style="font-family:Calibri,serif" %)Trauma patient 231 - 232 -(% class="western" lang="en-GB" %) 233 -(% lang="en-US" style="font-family:Calibri,serif" %)(e.g., a spinal cord injury) 234 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)((( 235 -(% class="western" lang="en-GB" %) 236 -(% lang="en-US" style="font-family:Calibri,serif" %)Neurodegenerative diseases 237 -))) 238 -|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)((( 239 -(% class="western" %) 240 - 241 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)((( 242 -(% class="western" %) 243 - 244 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)((( 245 -(% class="western" %) 246 - 247 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:147px" %)((( 248 -(% class="western" %) 249 - 250 -))) 251 -|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)((( 252 -(% class="western" lang="en-GB" style="text-align:center" %) 253 -(% lang="en-US" style="font-family:Calibri,serif" %)**Clients of a specific service** 254 -))) 255 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)((( 256 -(% class="western" lang="en-GB" %) 257 -(% lang="en-US" style="font-family:Calibri,serif" %)Child welfare 258 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 259 -(% class="western" lang="en-GB" %) 260 -(% lang="en-US" style="font-family:Calibri,serif" %)Nursing home 261 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 262 -(% class="western" lang="en-GB" %) 263 -(% lang="en-US" style="font-family:Calibri,serif" %)Employment service 264 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)((( 265 -(% class="western" %) 266 - 267 -))) 268 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:6px; padding:0in 0.08in; width:146px" %)((( 269 -(% class="western" lang="en-GB" %) 270 -(% lang="en-US" style="font-family:Calibri,serif" %)Early childhood education 271 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 272 -(% class="western" lang="en-GB" %) 273 -(% lang="en-US" style="font-family:Calibri,serif" %)Home care 274 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 275 -(% class="western" lang="en-GB" %) 276 - 277 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)((( 278 -(% class="western" lang="en-GB" %) 279 - 280 -))) 281 -|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)((( 282 -(% class="western" %) 283 - 284 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)((( 285 -(% class="western" %) 286 - 287 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:146px" %)((( 288 -(% class="western" %) 289 - 290 -)))|(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; padding:0in; width:147px" %)((( 291 -(% class="western" %) 292 - 293 -))) 294 -|(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)((( 295 -(% class="western" lang="en-GB" style="text-align:center" %) 296 -(% lang="en-US" style="font-family:Calibri,serif" %)**Vulnerable groups** 297 -))) 298 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:44px; padding:0in 0.08in; width:146px" %)((( 299 -(% class="western" lang="en-GB" %) 300 -(% lang="en-US" style="font-family:Calibri,serif" %)Minors/Children 301 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 302 -(% class="western" lang="en-GB" %) 303 -(% lang="en-US" style="font-family:Calibri,serif" %)Single parents with minor children 304 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 305 -(% class="western" lang="en-GB" %) 306 -(% lang="en-US" style="font-family:Calibri,serif" %)Persons subjected to psychological, physical or sexual violence 307 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)((( 308 -(% class="western" lang="en-GB" %) 309 -(% lang="en-US" style="font-family:Calibri,serif" %)Substance users 310 - 311 -(% class="western" lang="en-GB" %) 312 -(% lang="en-US" style="font-family:Calibri,serif" %)(drugs, alcohol) 313 -))) 314 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)((( 315 -(% class="western" lang="en-GB" %) 316 -(% lang="en-US" style="font-family:Calibri,serif" %)Disabled people 317 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 318 -(% class="western" lang="en-GB" %) 319 -(% lang="en-US" style="font-family:Calibri,serif" %)Victims of trafficking in human beings 320 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 321 -(% class="western" lang="en-GB" %) 322 -(% lang="en-US" style="font-family:Calibri,serif" %)Ethnic minorities and immigrants 323 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)((( 324 -(% class="western" lang="en-GB" %) 325 -(% lang="en-US" style="font-family:Calibri,serif" %)Isolated people 326 -))) 327 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)((( 328 -(% class="western" lang="en-GB" %) 329 -(% lang="en-US" style="font-family:Calibri,serif" %)Elderly people 330 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 331 -(% class="western" lang="en-GB" %) 332 -(% lang="en-US" style="font-family:Calibri,serif" %)Persons with serious illnesses 333 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 334 -(% class="western" lang="en-GB" %) 335 -(% lang="en-US" style="font-family:Calibri,serif" %)Homeless people 336 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)((( 337 -(% class="western" lang="en-GB" %) 338 -(% lang="en-US" style="font-family:Calibri,serif" %)Ex-prisoners and people with criminal background 339 -))) 340 -|(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)((( 341 -(% class="western" lang="en-GB" %) 342 -(% lang="en-US" style="font-family:Calibri,serif" %)Pregnant women 343 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 344 -(% class="western" lang="en-GB" %) 345 -(% lang="en-US" style="font-family:Calibri,serif" %)Persons with mental disorders 346 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)((( 347 -(% class="western" lang="en-GB" %) 348 - 349 -)))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)((( 350 -(% class="western" lang="en-GB" %) 351 - 352 -))) 353 - 354 -(% class="western" lang="en-GB" %) 355 -(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in Table . 356 - 357 - 358 358 |**Researcher expertise**|**Brief use case description** 359 359 |Policy Makers|Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making 360 360 |Experts in communication studies|Defining written, oral, visual and digital communication within a certain workplace. Evaluating (multi professional) healthcare team collaboration, communication and debriefing in various healthcare situations in simulated environments (especially in Simulation lab)